Testing times for diagnostics firm UGenix as Covid demand drops
The medical technology company is looking to list in Hong Kong after a windfall from Covid testing, but its other screening services are not yet lucrative Key Takeaways: Covid tests…
Genecast Hopes for High IPO Valuation Despite Red Ink, Regulatory Risk
The maker of cancer diagnostics and testing products has made a second filing for a Hong Kong IPO, even as its industry faces regulatory risk due to the newness of…
